Fibroproliferative disorders are the leading cause of death in the United States, 1 outstripping
cancer in numeric importance by more than 2: 1. According to vital statistics data published …

Benign and malignant fibroproliferative disorders (FPDs) include idiopathic pulmonary fibrosis,
hepatic cirrhosis, myelofibrosis, systemic sclerosis, Dupuytren’s contracture, hypertrophic …

… The paper is structured as follows: after a brief description of wound healing and
fibroproliferative disorders (Section 2) we will present the state of the art of mathematical models for …

Apoptotic cell death is a hallmark of inflammatory–fibroproliferative disorders of the vessel
wall. Here, we review what is currently known about cell death within atherosclerotic and …

Introduction Fibrosis is characterized by dysregulation and accumulation of extracellular
matrix. Peyronie's disease and Dupuytren disease are fibroproliferative disorders of the tunica …

… These findings support further study of 3-hydroxy-3-methylglutaryl–coenzyme A (HMG-CoA)
reductase inhibitors as potential therapy for patients with fibroproliferative disorders. …

… factors that are involved in mediating fibroproliferation (6), interrupting critical chemokine
signaling pathways could impact the pathogenesis of pulmonary fibroproliferative disorders by …

… advances have been made in recent years in understanding the molecular details of fibrosis
[6,7], the causes and potential therapeutic approaches of various fibroproliferative disorders …

… Apoptosis is the main feature of inflammatory-fibroproliferative disorders of the vessel wall.
Studies in animal models have shown that smooth muscle cells (SMCs) cultured from …

Fibroproliferative disorders include neoplastic and reactive processes (eg desmoid tumor …
from β-catenin driven fibroproliferative disorders. Nefopam decreased cell proliferation and β-…